Kenneth B. Kirby, President & Chief Executive Officer. Kenneth B. Kirby is the President and CEO for TDSC. Mr. Kirby is a pharmaceutist, entrepreneur and co-inventor of the HypoSpray® drug delivery platform, having partnered the exploratory research and written the science that became the intellectual property basis for the technology. Mr. Kirby received a B.A. in pre-medical studies from Florida State University and is a member of Phi Beta Kappa and the American Chemical Society. He has served on the faculty of both the Scripps Florida Institute and the Max Planck Florida Institute in oversight roles. He is an expert in regulatory compliance, chemistry manufacturing and controls and Good Manufacturing and Laboratory Practice.
Chandan A.S. Alam, BSc., M.D., Executive Vice President, CSO. Chandan A.S. Alam is the Chief Scientific Officer and a Founding Director. His main area of interest is transdermal drug delivery. Formerly Senior Research Fellow and co-head of the Experimental Pathology group at the William Harvey Research Institute, London, Dr. Alam has published 45 plus papers, posters and book chapters on angiogenesis, various animal models of disease and transdermal delivery of drugs, and has presented widely at international conferences. Dr. Alam received his BSc from London Guildhall University and his MD from St. Georges University School of Medicine, Grenada, WI.
Long H. Vu, Esq., Vice President, Global Business Development. Long H. Vu is the Vice President of Global Development for TDSC. Mr. Vu’s diverse legal and business development background has encompassed starting multiple businesses in the USA and internationally. A graduate of the William Richardson School of Law, Long H. Vu holds a JD in International Business law. Mr. Vu also holds a MBA in International Business from Boston University.
Deepak Basra, Vice President, Strategy & Development. Deepak Basra is the Vice President of Strategy & Development for TDSC. Mr. Basra has spent over twenty five years in senior executive roles with global corporations in the Technology and Healthcare sectors, including commercial leadership positions, Business Development/M&A and Corporate Strategy. A graduate of Edinburgh University, he holds a BSc in Social Sciences and an MBA from Henley Management College (UK)
Scientific and Medical Advisory Board Members
Gustav Born, M.D., Ph.D.
Fellow of the Royal Society, Research and Development Advisor, WHRI
Howard Maibach, M.D.
Professor of Dermatology, UC San Francisco
Developer of patch technology
Jane Shaw, Ph.D.
Co-inventor of the Scopalamine patch
Formerly President ALZA
Formerly Chairwoman Intel Corporation
Board Member, McKesson Corporation
Shern L. Chew, MD, P.D.
Professor of Endocrinology, Barts and the London
Atholl Johnston, Ph.D.
MRC Path, Clinical Pharmacology, WHRI
Richard Langford, MD, MRCS, FCRA
Deputy Director of Research
Professor of Anesthesiology
Laboratory and Director of Pain Clinic Barts and the London